Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS)
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Open source artificial pancreas systems (OpenAPS) have gained considerable interest in the diabetes community. We analyzed continuous glucose monitoring (CGM) records of 80 OpenAPS users with type 1 diabetes (T1D). A total of 19 495 days (53.4 years) of CGM records were available. Mean glucose was 7.6 ± 1.1 mmol/L, time in range 3.9–10 mmol/L was 77.5 ± 10.5%, <3.9 mmol/L was 4.3 ± 3.6%, <3.0 mmol/L was 1.3 ± 1.9%, >10 mmol/L was 18.2 ± 11.0% and > 13.9 mmol/L was 4.1 ± 4.0%, respectively. In 34 OpenAPS users, additional CGM records were obtained while using sensor‐augmented pump therapy (SAP). After changing from SAP to OpenAPS, lower mean glucose (−0.6 ± 0.7; P < 0.0001), lower estimated HbA1c (−0.4 ± 0.5%; P < 0.0001), higher time in range 3.9–10 mmol/L (+9.3 ± 9.5%; P < 0.0001), less time < 3.0 mmol/L (−0.7 ± 2.2%; P = 0.0171), lower coefficient of variation (−2.4 ± 5.8; P = 0.0198) and lower mean of daily differences (−0.6 ± 0.9 mmol/L; P = 0.0005) was observed. Glycaemic control using OpenAPS was comparable with results of more rigorously developed and tested AP systems. However, OpenAPS was used by a highly selective, motivated and technology‐adept cohort, despite not being approved for the treatment of individuals with T1D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weisman, A., Bai, J.-W., Cardinez, M., Kramer, C. K., & Perkins, B. A. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30167-5 · Cited by 463 · cited 2×
“1%) when comparing AP systems with SAP.(8) However, weighted mean time in target range for SAP therapy in this metaanalysis was 57.”
BackgroundInfluentialOpen Humans: a platform for participant-centered research and personal data exploration
Greshake Tzovaras, B., Angrist, M., Arvai, K., Dulaney, M., Estrada-Galiñanes, V., Gunderson, B., Head, T., Lewis, D., Nov, O., Shaer, O., et al. (2019) · GigaScience · doi:10.1093/gigascience/giz076 · Cited by 56
Self-citation
Cited by
Braune, K., Lal, R. A., Petruželková, L., Scheiner, G., Winterdijk, P., Schmidt, S., Raimond, L., Hood, K. K., Riddell, M. C., Skinner, T. C., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00267-9 · Cited by 130
The Do-It-Yourself Artificial Pancreas: A Comprehensive Review
Kesavadev, J., Srinivasan, S., Saboo, B., Krishna B, M., & Krishnan, G. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00823-z · Cited by 85
“%) to 6.27% [SD 0.67] %TIR 64.2% [SD 15.94] to 80.68% [SD 9.26] Melmer et al. 2019 Brief report To analyze CGM records of 80 patients with T1D using DIY closed loop systems and to compare the glycemic outcomes of SAP therapy to OpenAPS in 34 of the users Glycemic parameters of DIY closed…”
MethodInfluentialBraune, K., Gajewska, K. A., Thieffry, A., Lewis, D. M., Froment, T., O'Donnell, S., Speight, J., Hendrieckx, C., Schipp, J., Skinner, T., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/25409 · Cited by 67
Self-citation
Metadata
- Authors
- Melmer, A., Züger, T., Lewis, D. M., Leibrand, S., Stettler, C., & Laimer, M.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2019-07-05
- Volume
- 21
- Issue
- 10
- Pages
- 2333-2337
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2951726688
- Cited by
- 88
- References
- 2
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS). https://app.cochat.ai/papers/10.1111/dom.13810
- The paper
- Melmer, A., Züger, T., Lewis, D. M., Leibrand, S., Stettler, C., & Laimer, M. (2019). Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS). Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.13810
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.